First Citizens Bank & Trust Co. Has $248,000 Holdings in Encompass Health Co. (NYSE:EHC)

First Citizens Bank & Trust Co. boosted its position in shares of Encompass Health Co. (NYSE:EHC) by 14.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,687 shares of the company’s stock after acquiring an additional 332 shares during the period. First Citizens Bank & Trust Co.’s holdings in Encompass Health were worth $248,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in EHC. MassMutual Private Wealth & Trust FSB boosted its stake in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares during the period. UMB Bank n.a. grew its stake in shares of Encompass Health by 387.7% in the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after acquiring an additional 252 shares during the last quarter. V Square Quantitative Management LLC increased its position in Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares during the period. Avior Wealth Management LLC acquired a new position in Encompass Health during the 3rd quarter valued at $40,000. Finally, Tompkins Financial Corp bought a new stake in Encompass Health in the 4th quarter valued at $46,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Up 0.4 %

Shares of NYSE:EHC opened at $96.71 on Wednesday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a market cap of $9.74 billion, a price-to-earnings ratio of 23.36, a P/E/G ratio of 1.13 and a beta of 0.89. The company has a 50 day moving average of $96.63 and a 200-day moving average of $94.57. Encompass Health Co. has a one year low of $70.74 and a one year high of $104.55.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter in the previous year, the company posted $0.86 EPS. The business’s revenue for the quarter was up 11.9% compared to the same quarter last year. On average, sell-side analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current year.

Analyst Ratings Changes

EHC has been the subject of a number of research analyst reports. KeyCorp upped their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Barclays boosted their price objective on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Royal Bank of Canada lifted their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Finally, Truist Financial restated a “buy” rating and set a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Nine investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Encompass Health currently has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.